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INTRODUCTION

Arterial reconstructive surgery has been attended by a modest
early failure rate due to thrombosis of endarterectomized segments or
vein bypass grafts.

22

With the advent of coronary artery surgery,

the

importance of avoiding early failure due to thrombosis assumes even
greater importance as thrombosis can result not only in failure to increase blood supply to the myocardium but in mortality as well.

25

Thrombosis after surgical or other trauma to a vessel wall is most
likely initiated by adherence of platelets to the site of injury.

53

Therefore, attempts to reduce the incidence of thrombosis and consequent
failure of reconstructive vascular surgery can be directed at inter¬
rupting the initial platelet mediated steps.

A number of pharmacologic

agents have been shown in vitro and in vivo to affect platelets,
and an attempt has been made to apply one of these, dextran,
surgery in clinical practice.

31

59

to arterial

The present studies then were directed

at the development of a model for intra-arterial thrombosis which would
clot consistently and which would resemble the clinical situation.

Then,

the ability of two agents previously shown to have effects on platelets,
dipyridamole and aspirin, to alter the rate of thrombosis were tested
against this model.

Review of the Literature:

Early failure due to thrombosis constitutes an important
problem in most large series of arterial reconstructive procedures for

-2-

ischemic vascular disease of the lower limb.
early failure rates of 18% for saphenous

Gutelius ej: al.

reported

vein grafts and 30% for

endarterectomy in treating superficial femoral artery disease.
DeWeese e_t al.

reported a 287, early failure rate in femoro-popliteal

saphenous vein grafts
Darling £t

al_.

38

23

and 15% early failures with endarterectomy.

22

were somewhat more successful with only 7.8% early fail-

ures with femoro-popliteal vein grafts.

20

Vein grafts to tibial artery

segments with both proximal and distal arterial occlusions thrombosed
in 9 or 31 patients

reported by Mannick ej: al.

distal tibial arteries at the ankle,
failures due to thrombosis

52

In vein grafts to the

Garret et al.

in 57 cases.

34

reported 7 early

Harrison and his group reported

a 1007o patency rate at the end of hospitalization in 25 patients with
superficial femoral artery disease utilizing "eversion thromboendarterectomy",

but 4

(16%)

required reoperation before discharge because of

thrombosis of reconstructed segments.

41

Similar results were obtained

by Connolly et_ al. with eversion thromboendarterectomy.

14

Each of these

series of reconstructive procedures then was attended by a significant
early failure due to thrombosis.
Coronary artery surgery,
because of its recent advent,
Dilley e_t al.

although less extensively reported

shows similar early failure rates.

in an early report of endarterectomy for coronary disease

indicated that 127o of their 25 patients died with thrombosis
endarterectomized segment.

25

Mitchel and his group reported a series of

128 patients with saphenous vein grafts
least one graft.

56

However,

in the

in whom 10 had thrombosed at

8 additional patients died without any re¬

port on the status of their grafts.

Green et al.

described 6 patients

-3-

with thrombosed vein grafts among 82
failure rate was again not evaluated.

cases but the total early graft
36

Early thrombosis of a graft

or endarterectomized segment may be a significant problem in coronary
artery surgery as

it has been in peripheral vascular surgery.

Substantial evidence exists that platelets play a central
role in thrombus

formation after injury to the vessel wall.

depicted the role of platelets

Bizzozero

in thrombus formation in 1882.

6

Ashford

and Freiman found that simply grasping a vessel with a forceps produced
disruption of the endothelium of the vessel wall and resulted in the
formation of a thrombus composed primarily of platelets at the site of
3
injury.

French £t a_l.

of a small vessel,

found that after electrical injury to the wall

endothelial cells were lost from the intima of the

vessel wall and that platelet thrombi appeared at these sites within a
few seconds.

32

Spaet and Erichson

72

and Baumgartner et_ al.

similar findings regarding the role of platelets
vascular injury.

Zucker,

82

French eE ad..,

32

also emphasized the primary role of platelets
from the end of a transected artery.

5

reported

in thrombosis after

and Hovig ejt ad..

A-7

have

in the arrest of bleeding

The importance of platelets

in

thrombosis after arterial surgery has been demonstrated by Evans and
Mustard who found a significant correlation between platelet adhesive¬
ness

in a glass bead column and the onset of thrombosis after dacron

grafts,

endarterectomy,

Rowsell et: a_l.

or saphenous vein grafts.

29

In addition,

have found that thrombocytopenic swine will not form

thrombi in an extracorporeal shunt unless they are transfused with
platelet rich plasma.^

Thus,

platelets play a primary role in thrombus

formation after injury to the vessel wall,

and it seems very likely that

they are also involved in thrombosis after arterial reconstructive surgery.

-4-

The evolution of a platelet thrombus after vascular injury
involves a fairly well understood sequence of events

from the initial

sticking of platelets to the vessel wall through growth of the thrombus,
stabilization,

and ultimately organization.

shown that the initial event

in thrombus

Anatomic studies

3 32 72
’
’
have

formation is the adherence of

platelets to subendothelial structures after loss of the endothelial
cells,

or to perivascular connective tissue fibers after transection

of small vessels.

The substance

in the perivascular tissue which in¬

duces platelet aggregation has been reasonably certainly identified as
collagen by electron microscopy.

In vitro studies

have

clearly demonstrated the ability of collagen to induce platelet aggre¬
gation.

The loss of native structure by heating,

collagenase,

by treatment with

or by blocking the epsilon amino groups of lysine of the

collagen molecule results

in the loss of the ability of collagen to

induce platelet aggregation.

80

The nature of the substance

in the sub¬

endothelial layer of the vessel wall which induces platelet aggregation
after loss of the endothelium is still somewhat in doubt.

French and

his co-workers described platelets adhering to elastic tissue and fine
fibers.

32

Spaet and Erichson concluded,

however,

that collagen was

the

active substance in the subendothelial layer as suspensions of elastic
tissue did not

induce platelet aggregation in vitro.

72

Baumgartner e_t ah

more recently have described the adherence of platelets to a noncollagenous subendothelial structure after diffuse injury to the aorta
5
in an experimental animal.

Hughes and Mahieu have shown that basement

membrane prepared from renal tubules can induce platelet aggregation
in vitro and have hypothesized that the basement membrane in vessels

is

-5-

the important substance in bringing about platelet aggregation in vivo.
Several investigators

3 32 4-7 12
3
’
5
have stated that fibrin formation does

not seem to precede platelet adherence to any of these structures.
initial step in thrombus

The

formation then is the adherence of platelets

to one or more subendothelial or perivascular structures.
The exposure of platelets to these subendothelial and peri¬
vascular structures results not only in the adherence of platelets,
also in morphologic changes

in the platelets and the release of specific

active substances to induce further platelet aggregation.
contact with collagen fibers
loss of granules,

32

but

Platelets

in

in vivo show formation of pseudopodia,^

and breaks

in the cell membrane,

32

and similar

changes have been demonstrated in vitro with collagen induced platelet
aggregation.

45

These morphologic changes are associated with the re¬

lease of compounds which show further aggregating activity toward
platelets,

including adenosine diphosphate

,
u •
59,75
and epinephrine,
ADP was

plug.

^

•
. .
73
,
50
m a calcium
and energy dependent process.

initially demonstrated to aggregate platelets

Gaarder ej: aj..
changes

(ADP)^^>54,73 seroton^nj^4

33

and Born,

7

in vitro by

and has subsequently been shown to produce

in platelet shape similar to those found in a developing platelet
The application of ADP to areas of minor injury in vessels

to the enhancement of white thrombus

formation,

43 44
3
and the intravenous

infusion of ADP can increase the amount of thrombus
corporeal shunt,
platelet count,

decrease the clotting time,

formed in an extra¬

transiently decrease the

and cause the formation of platelet aggregates

vasculature of a variety of different organs

leads

60

in the

In addition, ADP in

sufficient concentration can cause the release of more ADP and serotonin

-6-

from platelets.Serotonin has also been shown to be capable of pro62
during platelet aggregation,

and of increasing the rate of thrombus
43 44

formation in areas of minor injury to a vessel wall.
ADP and serotonin,

catecholamines have been shown to have potent effects

on platelet aggregation.

Epinephrine and norepinephrine can induce

platelet aggregation in vitro,

54,63

ADP and serotonin from platelets.
hance the ability of collagen,
aggregation.

Along with

75

and can bring about the release of

54

Epinephrine can also markedly en-

thrombin,

75

2

and ADP

to

induce platelet

Of these three active agents released by the platelet

collagen interaction,

it is currently believed that ADP is

portant physiologically.
hypothesis comes

59

the most

im-

The most compelling evidence for this

from the observations

that

inhibitors of ADP aggrega¬

tion can inhibit aggregation induced by a variety of different agents
.
, ,,
.62
.
u .
62
including serotonin,
epinephrine,
while antagonists of catecholamines,

59

u
u.
42,62
J
73
thrombin,
and collagen,
serotonin,

not affect ADP mediated platelet aggregation.
of thrombus

43

Thus,

and thrombin

83

do

the initial stages

formation and growth after vascular injury result from a

specific interaction between collagen or other substances
wall and platelets
morphologic changes

from the blood.

This

leads,

in turn,

in the vessel
to specific

in the platelets and the release of active compounds

which then induce more platelets to aggregate around the site of

injury.

The future of the platelet thrombus at the site of injury then
depends

in part on the activation of the plasma coagulation system.

The aggregation of platelets

in vitro by collagen, ADP,

epinephrine,

and serotonin is associated with platelet factor 3 becoming available
to activate the plasma coagulation system.

39

This "factor"

is thought

7

-

-

to be a lipoprotein moiety which remains attached to the platelet mem¬
brane and serves as a catalytic site for the interaction of plasma
coagulation factors.

39,53

The activation of the plasma coagulation

factors results in the generation of thrombin and then fibrin,
in turn influence the fate of the platelet plug.

53 58
5

53

which can

Thrombin has

actions similar to those of collagen in inducing platelet aggregation,
producing morphologic changes, and causing the release of active substances.

42,54,62,73

In addition to its direct effects on platelets,

thrombin catalyses the conversion of fibrinogen to fibrin.

53

Both

Zucker*^ and Hovig and his group^ have demonstrated that the formation
of fibrin is necessary for the stabilization of the platelet plug.

In

experimental animals with clotting factor deficiencies who do not form
fibrin, the initial arrest of bleeding from the transected end of a
vessel by the formation of a platelet plug is followed by a high inci¬
dence of re-bleeding.^ ’ ^

The plasma coagulation system then is im¬

portant in the growth and stabilization of the platelet thrombus.
There is also some inconclusive evidence that the fibrinogen
component of the coagulation system is important in primary platelet
aggregation as well.

Cross found in vitro that the addition of

fibrinogen or plasma to washed platelets led to a marked increase in
the response of platelets to ADP. ^ Similar findings have been reported
by Weiss and Rogers in the study of two patients with cogenital
afibrinogenemia.

79

However, Gugler and Luscher reported normal platelet

aggregation in a similar patient.

37

The exact role of fibrinogen in

the primary processes of platelet aggregation remains somewhat unclear.

8-

-

With functioning platelet aggregation and plasma coagulation
systems, the final determinant of the extent of the thrombus formed
after vascular injury depends on the patterns of blood flow in the area
of the injury.

58

Mustard et: a_l. theorized that laminar flow would

favor the restriction of further thrombus growth by diluting the ADP,
serotonin, epinphrine, and thrombin as they are formed from the developing platelet plug.

58

Disturbed flow with eddy formation and areas

of stagnation would allow the buildup of these active substances and
favor the further growth of the thrombus.

58

This reasoning has been

verified by this group who found that diffuse injury to the aorta of a
pig resulted in the buildup of thrombus at areas of disturbed flow
such as the bifurcation, but caused only a thin layer of thrombus
formation in the areas of laminar flow.

58

This group of workers also

reported similar findings regarding the formation of thrombi in an
extracorporeal shunt.^

These observations correlate with clinical

observations that the chances for the success of saphenous vein grafts
are increased when they are inserted into non-diseased portions of the
vessel with good runoff and with the finding that endarterectomy has a
higher success rate when this procedure leaves a smooth transition be¬
tween the endarterectomized segment and the remainder of the vessel
wall.

23

With grafts inserted into diseased segments of vessel and in

endarterectomies without a smooth transition, turbulent flow with eddy
formation favors the accumulation of platelet aggregating substances.
Similarly, poor runoff favors the buildup of these substances because
of sluggish flow.

Thus, the pattern of blood flow through the injured

segment of vessel inlfuences the ultimate growth of the thrombus.

9-
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After the initial platelet-fibrin thrombus is formed,
gradually replaced with fibrin.

53 58
’

it is

The platelets gradually dissolve,

and over a period of time ranging up to 14 days the fibrin and platelet
remnants are phagocytosed by mononuclear cells and replaced by a mass
rich in smooth muscle and collagen covered by endothelium.

53

However,

if the thrombus has completely occluded the lumen the resolution of the
thrombus may leave a non-patent fibrous cord.
Numerous attempts have been directed at attempting to define
agents which would inhibit platelet aggregation.

The first group of

agents discovered were the structural analogues of ADP, adenosine and
g
2 chloroadenosine.

Born

found that the addition of either compound to

an in vitro system before the addition of ADP inhibited the normal
aggregation by ADP, and Born et: al. also reported that the intravenous
infusion of adenosine or 2 chloroadenosine prevented the formation of
a white thrombus at the site of an arterial injury."^

Clayton, Born,

and Cross then investigated other structural analogues of adenosine and
found that adenosine monophosphate (AMP) also inhibited ADP-mediated
platelet aggregation.

However, other compounds with small structural

changes in the adenosine moiety were lacking in activity.

13

Born £t al.

also noted that adenosine and 2 chloroadenosine had potent vasodilator
action

10

and subsequently investigated the relationship between the

vasodilating actions of adenosine analogues and their ability to inhibit
ADP mediated platelet aggregation.

Their findings showed a close cor-

relation between vasodilator and inhibitory activities.

9

Emmons e_t al.

then investigated dipyridamole because of its vasodilator actions and
because an earlier report by Bunag had shown that dipyridamole could in-

10-

-

crease the adenosine level in whole blood.

12

This group found that incu¬

bation of dipyridamole with platelet rich plasma decreased aggregation
by ADP.

27

In addition, they found that an intravenous infusion of

dipyridamole markedly decreased the formation of thrombi at sites of
vessel injury.

28

However,

long term human ingestion did not affect

platelet aggregation in vitro induced by ADP,
phrine.

27

serotonin, or norepine-

Didisheim subsequently showed that dipyridamole decreased

the rate of occlusion of mesenteric vessels after electrical injury in
the rat.

24

Further studies have revealed that dipyridamole inhibits

platelet aggregation induced by collagen and thrombin in vitro,
and inhibits the release of ADP
platelet aggregating agents.

17 59

3

17 59
17 59 84
*
and serotonin
’
3
by these

Dipyridamole given in vivo inhibited plate¬

let aggregation induced in vitro by collagen and thrombin and increased
the bleeding time from the cut end of a mesenteric vessel in rabbits.^
These studies have also indicated that dipyridamole decreases the uptake
,
17
,
.
17,69
and serotonin"^ by platelets, and it has
of glucose,
adenosine
been hypothesized that its actions result from this generalized metabolic
inhibition.

69

Dipyridamole has very recently been shown to decrease

the rate of thrombosis after mechanical endarterectomy in dogs,
decrease the platelet turnover
plications

74

40

18

to

and incidence of thromboembolic com-

in patients with prosthetic heart valves, and to decrease

28
the amount of platelet aggregation in a heart lung pump oxygenator.“
In addition to dipyridamole, Emmons ej:
prostaglandin

al.

also investigated

28
because of its vasodilator effects.^

They found that

PGE^ inhibited ADP, serotonin, thrombin and norepinephrine induced
platelet aggregation, and decreased the amount of thrombus formation in

11-

-

26

injured vessels.*"

Further studies have shown that collagen induced

aggregation is also inhibited by PGE^,

and that PGE^ will decrease the

release of radioactively labeled serotonin from platelets exposed to
collagen and thrombin.Kinlough-Rathbone ej: al.

suggested that these

effects on platelets might result from the actions of PGE^
intra-platelet cyclic AMP,"*^ but Ball et ajL.

to increase

could not find a correla¬

tion between platelet cyclic AMP and inhibition of collagen induced
platelet aggregation.

4

However,

they did find that theophylline,

a

methyl xanthine which inhibits the phosphodiesterase enzyme which
breaks down cyclic AMP,

enhanced the effects of PGE^ to inhibit collagen
4

induced platelet aggregation.

Salzman has concluded in a recent re¬

view that the role of cyclic AMP in platelet aggregation and in its
inhibition by compounds such as PGE-^
investigation.

is not clear and bears

70

Because of the evidence of the
in platelet aggregation,

various

importance of catecholamines

inhibitors of the cardiovascular ac¬

tions of the catechols have been investigated.
blocking agent,
aggregation

63

further

Phentolamine,

an alpha

has been shown to inhibit epinephrine induced platelet
In addition,

alpha blocking agents can reduce the

ability of collagen and thrombin to induce platelet aggregation.
Significantly,

75

the beta blocking agent propranolol was much less effective

in inhibiting platelet aggregation.Thus,

an alpha receptor has been

postulated to reside on the platelet membrane which is closely involved
in platelet aggregation.
The non-steroidal anti-inflammatory drugs constitute another
class of agents which have effects on platelets.

Mustard et al.

found

12-

-

that sulfinpyrazone could increase the platelet survival in rabbits
although it did not significantly affect the formation of thrombus in
an extracorporeal shunt.^

Packham et al.

found that the addition of

phenylbutazone or sulfinpyrazone to platelet rich plasma decreased the
platelet aggregation induced by collagen,
ADP and serotonin released.^

and decreased the amount of

They also found that phenylbutazone

could prolong the bleeding time from cut ends of mesenteric vessels.
However,

they could demonstrate no change in the response of platelets

to thrombin.^
pounds,

65

in addition to these pyrazole anti-inflammatory com¬

aspirin has been shown to have marked effects on platelets and

hemostasis.

Gast reported that aspirin decreased platelet "stickiness",

increased the bleeding time,

and increased the incidence of post

tonsillectomy hemorrhage from 0.1% to 8.7%.

35
Weiss and Aledort then

reported that an oral dose of 3 grams of aspirin per day inhibited
platelet aggregation induced by a connective tissue suspension in vitro
and increased the bleeding time,
gation of platelets.^

but did not affect ADP-induced aggre¬

Evans ej: al_.

then showed that aspirin added to

platelet rich plasma inhibited aggregation induced by collagen,
thrombin,

and antigen antibody complexes,

and simultaneously reduced

the release of ADP and serotonin in response to these aggregating substances.

30

They also found that aspirin administration prolonged the

platelet survival and reduced the amount of thrombus
extracorporeal shunt.

30

forming in an

Zucker and Peterson confirmed the effects of

aspirin on serotonin release and also found that aspirin decreased the
availability of platelet factor 3 after exposure of platelets to
aggregating stimuli.

85

Weiss ej: aJL.

reported similar findings regarding

13-

-

the effects of aspirin on aggregation and release of ADP by connective
tissue,

and also found that aspirin reduced platelet aggregation in

response to epinephrine.

78

Danese _et al.

found that aspirin reduced the

amount of thrombus formed after chemical and mechanical injury to the
vessel wall in dogs.^5^

The mechanism by which aspirin inhibits

platelet aggregation has been investigated by Al-Mondhiry et_ al.,

and

this group concluded that it may result from acetylation of active
sites on the platelet membrane.'”
An additional class of agents which affect the biological
membranes has been shown to inhibit platelet aggregation.
this group are a variety of antihistamines
diphenhydramine.

Included in

including promethazine and

Both of these agents have been reported to decrease

platelet aggregation in response to ADP,

epinephrine,

and collagen.

A second group of membrane active drugs with effects on platelets are
the tranquilizers and antidepressants.
imipramine,
inhibit ADP,
well.'*'*

nortryptiline,
epinephrine,

Chlorpromazine,

amitryptiline,

and norimipramine have all been shown to
and collagen induced platelet aggregation as

The local anesthetics comprise a third group of membrane

active drugs with lidocaine,

cocaine,

hibit platelet aggregation in vitro.

and nupercaine reported to in-

64

The precise mechanisms of

action by which these various drugs act are unknown,

but they have been

classified together by Mustard and Packham because each has been demonstrated in some systems to have effects on biological membranes.

59

They have hypothesized that this common feature may underly their
ability to alter platelet aggregation.

59

14-
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Despit e the large number of agents demonstrated in a variety
of experimental situations to affect platelets,

only two agents have

received any clinical application in arterial surgery.

Heparin has

been employed because of its effects on plasma coagulation factors,
it has also been shown to have effects on platelets.

59

but

It can inhibit

thrombin induced aggregation of platelets and release of platelet
constituents,

59

but

it is

ineffective against the actions of collagen

on platelets except at concentrations greater than 10 units/ml
(10 mg/100 ml).

59 71

3

This

latter dosage is equivalent to approximately

8 mg/kg which is almost three times the generally accepted dose for full
heparinization.

In addition,

heparin does not inhibit ADP induced

platelet aggregation even at these high doses.
prolong platelet survival in man.
with "difficult situations"

59

59

However,

Salzman has reported that patients

in peripheral artery reconstructions were

not aided by the addition of heparin to the regimen.
results have been achieved with the use of dextran.
employed clinical dextran

heparin does

71

Somewhat better

Moncrief jet al.

(average molecular weight 70,000) with autologous

end to end vein grafts to the femoral arteries of dogs.

This group re¬

ported an increase of over 100% in the patency rate with dextran.^
Winfrey and Foster utilized low molecular weight dextran
molecular weight 40,000)
means over a 2

(average

during removal of the intima by mechanical

cm length of artery with almost 5 times as many vessels

patent in the dextran as compared to the control group.

81

Foster et. al.

have reported that the employment of low molecular weight dextran im¬
mediately post operatively has significantly increased their success
rate in peripheral arterial reconstructions.^

Recent work has

15-

-

demons tra ted clinical dextran

(macrodex) with an average molecular

weight of 70,000 could increase the bleeding time and decrease platelet
adhesiveness when given to patients.

However,

Cronberg and his group

were unable to reproduce the effects on platelet adhesiveness when
macrodex was added to platelets

in vitro.

15

Similar but less potent

effects were observed with low molecular weight dextran by this group.

15

Macrodex also has been shown to markedly reduce factor VIII activity in
the blood,

but the importance of this

finding remains unclear as the

role of factor VIII in platelet aggregation is not known.
In summary,

then,

peripheral and coronary arterial recon¬

structive surgery are complicated by a recognized early failure rate
due to thrombosis in most series,
is

initiated by platelets.

and it is

The events

likely that this thrombosis

in arterial thrombosis are

reasonably well defined with platelet adherence to collagen or other
subendothelial substance leading to the release of platelet aggregating
substances

from these adherent platelets.

The platelet thrombus

is then

stabilized with fibrin via the plasma coagulation system with the pat¬
tern of blood flow being an important determinant of the ultimate ex¬
tent of the thrombus.

Several agents have been shown to affect plate¬

lets and to alter thrombus
variety of mechanisms.

formation after experimental injury via a

Relatively few attempts,

however,

have been made

to apply these clinically to arterial reconstructive surgery.

16-
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MATERIALS AND METHODS

The initial efforts

in this

study were directed at developing

an arterial model which would parallel as closely as possible the events
in clinical arterial surgery but which would also provide a consistently
clotting system against which various agents could be evaluated.
adult mongrel dog was chosen as the experimental animal,
weighed between 22 and 28 kg.

respirator.

and all dogs

Intrabenous sodium pentobarbital

(25 mg/kg) was employed for anesthesia,
supine on the operating table,

The

and all animals were placed

intubated,

and maintained on a volume

Intravenous gallamine in 10 mg doses provided supplemental

anesthesia.
In Group I,

consisting of 25 vessels

in 13 dogs,

4 cm segments

of femoral artery between the inguinal ligament and the knee,

or 4 cm

segments of common carotid artery were isolated under sterile condi¬
tions and the side brances were ligated and divided.

All vessels mea¬

sured between 4 and 5 mm in external diameter after dissection.
flow was

Blood

interrupted between atraumatic vascular clamps and a 3 cm

logitudinal arteriotomy was created with Potts arterial scissors.

A

mechanical endarterectomy was then performed using an ordinary chemical
spatula to develop a plane of dissection.
closed with a running 6-0 everting suture.

The arteriotomy was

then

Prior to the last stitches

both proximal and distal occlusions were temporarily removed to flush
blood clot forming secondary to stasis.
Group II consisted of 11 vessels

in 7 dogs and was

to Group I except that the brachial arteries were employed.
this group measured 2

to 3 mm in diameter after dissection.

identical
Vessels

in
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In Group III,

consisting of 10 vessels

in 7 dogs,

4 cm segments

of femoral artery were isolated and the side branches were ligated and
divided under sterile conditions.

The following procedure was then

employed to remove the intimal and muscularis
Blood flow was

layers of the vessel wall.

interrupted between vascular clamps,

and a solution con¬

taining 1 gram of the proteolytic enzyme pronase in 400 cc of normal
saline

(0.25%) was prepared.

This solution of enzyme was

then perfused

for thirty minutes through the isolated segment of artery at 200 cc per
minute via canulas inserted into two small longitudinal arteriotomies
at either ends of the isolated segment.

After perfusion,

the vessels

were flushed thoroughly with normal saline to remove residual pronase
solution.

The arteriotomies were then closed with 6-0 everting sutures

and blood flow restored.
Group IV consisted of 6 vessels
this group was

in 4 dogs.

The procedure in

identical to that performed in Group III except that

the perfusate consisted of normal saline instead of pronase.

All ves¬

sels were removed at 6 hours after perfusion.
In Group V,
was

consisting of 10 vessels

in 5 dogs,

the procedure

identical to that in Group III except that the dogs were given 250 mg

of dipyridamole by mouth each day for 4 days prior to operation and then
continued until the time of sacrifice at

intervals

from 6 hours to 6

weeks after operation.
Group VI consisting of 10 vessels
Group V except that 40 grains of aspirin

in 5 dogs was

similar to

(approximately 2.6 grams) was

given to the animals the day preceding operation and each day thereafter
until sacrifice 6 hours to 10 days after operation.
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Patency of the vessel was determined in vivo by palpation of
the femoral artery pulse distal to the site of perfusion,
sacrifice by direct examination of the vessels.
scopic sections were made of all vessels.
toxylin and eosin,

and at

In addition,

two micro-

One was stained with hema¬

the other with Masson trichrome.

The effects of pronase on the plasma coagulation system were
evaluated by adding 4 drops of the 0.25% pronase solution to a plain
glass test tube and to a citrated tube of venous canine blood.
White,

prothrombin,

Lee

and partial thromboplastin times were determined

in the hospital laboratory.
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RESULTS

In Group I,
to endarterectomy,
blood flow.
membrane,

of the 25 femoral and carotid arteries

subjected

9 clotted within 6 hours after the restoration of

Microscopy demonstrated that the intima,

and part of the muscularis

mechanical endarterectomy.

internal elastic

layers had been removed by the

In all cases

to the damaged areas of the vessel wall,

there were platelets adherent
but in 16 vessels this was

not sufficient to occlude the lumen of the vessel.
In Group II,

of the 11 brachial arteries endarterectomized,

6 clotted within 6 hours.

Microscopic findings were similar to those

found in Group I.
In Group III,

all 10 vessels perfused with pronase showed

loss of pulsations distal to the perfusion site within 3 hours after
the restoration of blood flow.

Gross

inspection of the vessels showed

clot occluding the lumen in the area of perfusion.

Microscopy demon¬

strated that the intima and part of the muscularis

layers of the wall

had been removed by the proteolytic action of the pronase.

The thrombus

occluding the lumen was composed of a platelet mass containing fibrin
with trapping of red and white blood cells,
perfused with pronase.
In Group IV,
occluded in 6 hours,

and was confined to the area

(Figure 1).
none of the vessels perfused with saline became

at which time the dogs were sacrificed.

Two of

these 6 vessels were in dogs which had perfusion of pronase in the
contralateral femoral artery which led to thrombus

formation.

Micro¬

scopy of the saline treated vessels revealed no disruption of the vessel
wall and no thrombus formation.

(Figure 2).
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In Group V, of the 10 vessels perfused with pronase in
animals treated with dipyridamole,

3 clotted acutely, 2 were patent at

sacrifice 6 hours postoperatively, and 5 remained patent until sacrifice
at 2 to 6 weeks after operation.

In the vessels studied at 6 hours

after perfusion, a slight amount of clot was seen grossly, and micro¬
scopic examination showed a thin layer of platelets and fibrin along
the portion of the vessel perfused with pronase.

(Figure 3).

In the

vessels studied at 2 to 6 weeks no clot was seen grossly and the inside
of the vessel was covered with a smooth shiny lining.
examination, no platelet fibrin clot was seen.

On microscopic

The luminal surface of

the vessel wall at 2 weeks after the time of perfusion showed a fibro¬
blastic proliferation in the intimal area which appeared to be covered
by a layer of endothelial cells

(Figure 4).

No unusual problems with

hemostasis were noted in this group of dogs receiving dipyridamole.
In Group VI, of the 10 vessels perfused with pronase in
animals receiving aspirin,
to 10 days after operation.

9 remained patent until sacrifice at 6 hours
With this dose of aspirin there appeared

to be a marked hemostatic defect.

Even the smallest arterioles and

venules required ligation or cautery for hemostasis.

One animal not

included in the above results died from massive and uncontrollable
hemorrhage from arteriotomy suture lines despite all measures.
animal,

A second

included in the series, developed large hematomas in both groins

after operation.

At 6 hours after perfusion pulses were palpable and a

moderate amount of clot was visible on the vessel wall on gross examina¬
tion.

The microscopic findings were similar to those in the vessels

examined 6 hours postoperatively in Group V with a layer of platelet
fibrin thrombus adherent to the damaged areas of the vessel wall.
findings in longer term vessels were similar to Group V vessels.

The
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DISCUSSION

Groups I and II demonstrated that mechanical endarterectomy
over a 3 cm length of vessel can produce a significant early thrombosis
rate.

The thrombosis rate is clearly related to the size of the vessel

involved as femoral and carotid vessels measuring 4 to 5 mm in diameter
became occluded with thrombus 36%, of the time while the incidence of
occlusion increased to 60% in the 2 to 3 mm brachial arteries.

The

rates of occlusions, however, are less than those reported by Winfrey
and Foster, who had a 95% occlusion rate after similar procedures in
dogs

81

with 3.5 mm vessels.

Microscopic examination in this study

showed that platelets were involved in the thrombus formation in ac¬
cordance with previously cited observations of the events following
injury to the inner layers of the vessel wall.

3

Because these mechanical

endarterectomies did not provide a model of arterial thrombosis which
would consistently lead to occlusion of the vessel a second model was
explored.
Perfusion of segments of artery with a 0.257, pronase solution
had previously been shown to remove the intima and a variable amount of
media from the vessel wall depending on the length of perfusion.
These findings were confirmed by Group III of this study.

49 67
*

After the

restoration of normal blood flow, all vessels perfused with pronase
developed thrombi which completely occluded the lumen within 3 hours.
In accordance with previously cited observations of thrombosis following
arterial injury

3

microscopy showed platelets adherent to the damaged

area of the vessel wall with the formation of fibrin and the trapping of
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red and white blood cells.

The effect of pronase on the vessel wall is

similar to that resulting from mechanical endarterectomy in that the
intima and part of the muscularis layers are removed.

The 100%

thrombosis rate after this enzymatic endarterectomy is clearly much
higher than that resulting from mechanical endarterectomy.

However, as

vessels perfused with saline in Group IV did not show any thrombus
formation,

it was felt that the occlusion rate in Group III did not re¬

sult from technical factors.

Pronase has been shown in vitro to induce

platelet aggregation by Davey and Luscher,

21

and it is possible that a

small amount of pronase remaining on the vessel wall would have a
direct effect on the blood to enhance thrombus formation.

This effect

was believed to be minimized by flushing the vessel with saline several
times after the perfusion with pronase and before the restoration of
blood flow.

In addition,

it should be noted that the concentration of

pronase used by Davey to induce platelet aggregation was four times
that used in the initial perfusate in the present experiments.

After

flushing with saline and restoring blood flow, the pronase would likely
be diluted even further, so that it seems unlikely that the direct
action of pronase on platelets was responsible for the 100% thrombosis
rate.

The finding that the Lee White, prothrombin, and partial thrombo¬

plastin times were not altered by the addition of small amounts of
pronase solution to samples of venous blood is some evidence that the
thrombosis did not result from a direct effect of pronase on the blood.
It would appear that pronase produces some change in the vessel wall
which makes it more thrombogenic than a vessel after mechanical endarterec¬
tomy although the nature of this change is not clear.
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Dipyridamole given at a dose of 250 mg per day to the animals
in Group V appeared to play a role in preventing thrombotic occlusion
in a significant percentage (70%) of the vessels perfused.

This effect

most likely results from its effects on platelet aggregation.

The

findings in this group correlate well with previous studies demon¬
strating the ability of dipyridamole to reduce thrombus formation
in vivo.

17 18 24 28
3
3
3

In particular, Danese and Haimov reported that

100 mg of dipyridamole in 16 kg dogs would decrease the rate of occlusions 4 hours after endarterectomy.

18

However, Danese,

Voleti, and

Weiss found that 200 mg dipyridamole per day did not decrease the rate
of occlusion 2 days after endarterectomy or injury with sulphuric acid.

19

The reasons for the latter findings are unclear, but in neither of
these reports was a 1007o rate of occlusive thrombus formation utilized
as a control.

The model using pronase in the present study was employed

to provide this type of consistently clotting arterial mocel.

Signif¬

icantly dipyridamole did not inhibit thrombus formation completely as a
layer of thrombus was demonstrated on the vessel wall 6 hours after
restoration of blood flow.

The effect seemed to be to reduce the growth

of the thrombus and thus to prevent occlusion of the lumen of the vessel.
This correlates with the in vitro findings that dipyridamole does not
affect platelet adhesion to collagen but does decrease the release of
ADP and serotonin from platelets exposed to collagen as well as decreasing
the ability of platelets to aggregate in response to ADP.^
Aspirin administration to the dogs in Group VI also provided
significant protection against the development of thrombotic occlusion
after perfusion with pronase.

Both of the series reported by
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Danese et

demonstrated significant protection by aspirin

against thrombotic occlusion after endarterectomy or chemical injury.
The dose of aspirin employed in the present study, however, was much
higher than that used by Danese et ad.., and may be responsible for the
marked hemorrhagic tendency found.

In vitro studies have shown marked

effects of aspirin on platelet aggregation,

30 78 8-4 85
5
5
5
and thus it is

likely that the protection afforded by aspirin in Group VI is also
mediated by the effects of this drug on platelets.

Similar to the ef¬

fects of dipyridamole, aspirin did not inhibit thrombus formation but
did decrease the rate of complete occlusion.
The ability of dipyridamole and aspirin to reduce the inci¬
dence of thrombotic occlusion after enzymatic removal of intima and
muscularis, as shown in this study, may have clinical application.
arterial reconstructive surgery, especially in small vessels,

In

the use

of either or both of these agents may reduce the early failure rate due
to thrombosis.

As discussed previously, Foster et

al.

reported that the

use of low molecular weight dextran immediately postoperatively in¬
creased the early patency rate in their series of peripheral vascular
reconstructions.

Similar use of either aspirin or dipyridamole might be

employed on an experimental basis,

ideally in a double blind prospective

study with patients matched as closely as possible.

Such a study seems

warranted in view of the in vitro findings of the activities of these
drugs on platelets,

59

the experimental animal work in the present study

and in those of Danese et 31.,^’^ and the findings of the beneficial
effects of these agents on platelet turnover and embolic complications
of prosthetic heart valve replacement.

40 74
’

The problems with the use
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of such agents, especially in surgical patients, are obviously those of
hemostasis.

With the systemic administration of a drug with potent

effects on the primary means of defense against hemorrhage,

there is

certainly risk of significant morbidity and mortality during surgical
procedures.

A more ideal means of preventing thrombosis in a local

area, such as in reconstruction of a particular arterial system,

is to

apply an agent in that local area which would have effects only in that
area.

Two agents described in the literature would fit these criteria,

adenosine and Prostaglandin E^.

Both agents have very potent effects

on platelets and both are rapidly degraded in the blood stream.

In

this way, the effects of either agent applied via an intra-arterial
canula to a particular arterial system might be restricted to that
arterial system.

Unfortunately, dogs will not tolerate an indwelling

canula over any length of time and it was not possible to test this
idea against the present model of thrombosis.

Ultimately, however, the

latter approach may be more applicable than the induction of a generalized
hemostatic effect to reduce thrombus formation in a limited area.
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FIGURE LEGEND

Figure 1 —• Longitudinal section through one side of vessel wall (35X)
showing thrombus

(T) adherent to the media (M) after di¬

gestion of the intima and inner layers of media with pronase.

(A) indicates the adventitial surface.

Figure 2 — Longitudinal section through one side of vessel wall
after perfusion with saline.
intimal layer.

(100X)

(I) indicates the intact

(M) represents media.

(L)

is the lumen of

the vessel.

Figure 3 — Longitudinal section through one side of vessel wall

(100X)

from animal treated with dipyridamole 6 hours after perfusion
with pronase.

The amount of thrombus

(T) is markedly re¬

duced compared to that occurring after perfusion with pro¬
nase without prior administration of dipyridamole.
(A) represent luminal and adventitial surfaces.

(L) and

There is

hemorrhage into the medial layer (M) of the vessel wall.

Figure 4 — Longitudinal section through one side of vessel wall (430X)
two weeks after perfusion with pronase in animal treated
with dipyridamole.

(F) refers to an area of fibroblastic

proliferation on the luminal
(M) denotes media.

(L) surface of the vessel wall.
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